Chronic Ischemic Left Ventricular Dysfunction From Pathophysiology to Imaging and its Integration Into Clinical Practice by Rahimtoola, Shahbudin H. et al.
FC
F
S
V
T
J
L
a
C
m
c
o
m
h
n
I
S
w
k
I
F
U
M
R

e
C
U
C
S
M
(
R
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 1 , N O . 4 , 2 0 0 8
© 2 0 0 8 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / 0 8 / $ 3 4 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 0 8 . 0 5 . 0 0 9R O M P I C T U R E S T O P R A C T I C E P A R A D I G M S
hronic Ischemic Left Ventricular Dysfunction
rom Pathophysiology to Imaging and its Integration Into Clinical Practice
hahbudin H. Rahimtoola, MB, FRCP, MACP, MACC, DSC (HON),*
asken Dilsizian, MD, FACC,† Christopher M. Kramer, MD, FACC,‡
homas H. Marwick, MBBS, PHD, FRACP, FESC, FACC,§
ean-Louis J. Vanoverschelde, MD, PHD, FACC
os Angeles, California; Baltimore, Maryland; Charlottesville, Virginia; Brisbane, Australia;
nd Brussels, Belgium
hronic ischemic left ventricular dysfunction is present in a number of clinical syndromes in which
yocardial revascularization results in an improvement of left ventricular function, patients’ functional
lass, and their survival. Early diagnosis of and treatment of viability is essential. Coronary arteriography is
f limited value in diagnosis of viability. Noninvasive testing is essential for diagnosis, which can be
atched to the pathophysiologic changes that occur in hibernatingmyocardium. However, no single test
as a perfect, or near perfect, sensitivity and specificity, and thus, a combination of tests are usually
eeded. Algorithms are developed to integrate these tests in clinical decisionmaking. (J AmColl Cardiol
mg 2008;1:536–55) © 2008 by the American College of Cardiology Foundationu
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8.cientific discoveries tend to be made not by those
ho seek to prove a hypothesis, but by those who
eep their eyes open . . .
Isaac Newton
Albert Einstein (1)
t was believed that left ventricular (LV) dys-
function (LVD) at rest was the result of
ongoing ischemia or myocardial infarction.
Thirty-three years ago, studies of patients
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f HM to be clinically acceptable. In the
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537Hibernating myocardium has been documented
in a number of clinical syndromes besides angina
(stable/unstable). These include acute myocar-
dial infarction, LV aneurysm, heart failure,
aborted sudden death, anomalous left coronary
artery from the pulmonary artery, and valve
disease with LV dysfunction.
Revascularization of HM results in an improve-
ment of regional and global LV systolic function
(4), remodeling is reversed (5,6), survival is
increased (7), and there is a decrease of the
composite of myocardial infarction, heart failure,
and unstable angina (8). Importantly, revascular-
ization of LVD in the absence of significant
amounts of viable myocardium was not of de-
monstrable beneficial clinical effects (7).
The lumen of the vessel distal to a severe
coronary obstruction is related to disease of the
vessel as well as to the amount of myocardial
blood flow (MBF). After revascularization, the
lumen may increase depending on the increase of
MBF (2). The ability to judge the amount of
MBF from a coronary arteriogram is limited.
Moreover, when the reduction in MBF is large
at rest, even a “small” increase of MBF with
revascularization may improve patient outcomes
but to a greater degree (Table 1).
One vessel disease can also result in changes in
the remote areas without associated coronary
artery disease. The remote areas show: 1) re-
duced coronary vasodilator reserve and altered
metabolism (9); 2) histological changes similar to
those seen in areas of HM in an experimental
study with left anterior descending artery steno-
sis (10); and 3) improvement/normalization of
LV function after revascularization of the areas
of HM with left anterior descending coronary
artery occlusion (6).
About two-thirds of patients with heart failure in
the developed world have underlying coronary
artery disease, and these patients have a signifi-
cantly worse prognosis than patients with nonisch-
emic heart failure (11). In the CHRISTMAS
(Carvedilol Hibernating Reversible Ischaemia
Trial), 29% of patients had HM and 19% had
reversible perfusion defect (12); these patients had
greater improvement of LV function.
Early revascularization of HM is associated with
greater improvement of LV function (7) and also
of patient survival (13).
There are major limitations to diagnosing HM
by invasive techniques. tThese findings have emphasized the need for and
mportance of noninvasive tests to diagnose and
uantitate the viable myocardium in areas of LV
ysfunction.
This review is limited to assessment of myocar-
ial viability only in chronic LVD and will not
ttempt to differentiate between stunning and hi-
ernation. It will focus on the important issues for
he noninvasive cardiac imager, namely: 1) patho-
hysiology of myocardial hibernation as it pertains
o the imager and imaging targets; 2) identification
f viable myocardium and prediction of functional
utcomes by various imaging modalities;
) integrated imaging schema that can be
sed in the clinical setting to identify a
iable myocardium; and 4) issues involved
n clinical decision making.
athophysiology of Chronic LVD
low-function alterations. EXPERIMENTAL
TUDIES. The fundamental derangement
s reduced MBF, specifically subendocar-
ial MBF (SE-MBF). In normal animals,
he subendocardium governs transmural
ontraction and the subendocardium re-
eives more MBF per unit of muscle than
he epicardium (14) (Table 2). In con-
cious dogs, there is a sensitive coupling
etween SE-MBF and function so that
nly a 20% reduction in SE-MBF (15) can
ause severe regional dysfunction, and the
elationship between systolic thickening
nd SE-MBF is more or less linear and
ependent on the hemodynamic situation
16). There is a 2 to 1 relationship in the
eduction of SE-MBF to reduction of
ransmural MBF (TM-MBF) (16–19).
or example, a 25% reduction in TM-
BF results in a 50% reduction in SE-
BF (Fig. 1). A 50% reduction in TM-
BF in an anesthetized dog (20) and 75%
eduction in SE-MBF in the conscious dog results
n akinesis of the LV wall; whereas subepicardial
BF does not correlate to transmural LV wall
unction (14). In animals with coronary arterial
bstruction following relief of ischemia, the
schemia-induced vasodilation is maldistributed in
he myocardium supplied by the obstructed coro-
ary artery, possibly due to microcirculatory
hanges. As a result, the increased volume of MBF
rom the hyperemia is directed to a greater extent to
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538schemic at least for a period of time (21). Thus,
elief of ischemia and even restoration of TM-MBF
oes not necessarily mean SE-MBF is normal or
as been restored to pre-ischemic levels.
Some studies of acute and short-term cardiovas-
ular manipulations in animals have shown that
pisodes of ischemia lead to the development of
M (22).
Experimental studies of adaptation to chronic
xed coronary stenosis have shown: 1) MBF may be
ormal or only mildly diminished in the early
eriod but regional contraction may already be
educed (stunning), but over the subsequent period,
eduction in MBF and function are matched (hi-
ernation) (14,23); and 2) progression to matched
ecreases in flow and function (HM) also occurs
ery early when a 15-min partial coronary occlusion
s followed by reperfusion through a critical stenosis
hibernation) (10).
LINICAL STUDIES. The few studies that showed
hat blood flow was “not reduced” measured only
M-MBF by positron emission tomography
PET); at that time, it was not possible to measure
E-MBF in humans. The weight of evidence
hows that patients with HM have reduced TM-
BF at rest (14), which implies SE-MBF is
ignificantly reduced to a much greater extent.
Until recently it was not possible to measure
E-MBF in humans with any degree of precision.
sing cardiac magnetic resonance (CMR) imaging,
elvanayagam et al. (24) have documented in pa-
ients with HM that SE-MBF is reduced at rest
hen compared with areas without significant cor-
nary stenosis in the same patients, and following
evascularization, SE-MBF and LV function are
ormalized/improved (Fig. 2). This led Klocke (25)
o conclude that this study “provides convincing
vidence for the hibernation paradigm” (25).
ORONARY FLOW RESERVE. Coronary flow reserve
CFR) is reduced in people with hyperlipidemia, in
hose with coronary atherosclerosis, and in patients
Table 1. Suggested Change in Patient Outcomes With the Same
Chan
MBF
Clinical
Situation Before After
Increase
of MBF
A 100 130 30
B 30 60 30
CCVS  Canadian Cardiovascular Society; MBF  myocardial blood ﬂow (ml/mith obstructive coronary artery disease. Thus, re-uced CFR is not just a phenomenon of HM or
tunning.
Irrespective of rest flow, CFR is almost always
educed in viable but dysfunctional myocardium,
lbeit more severely in segments with low flow at
est. The severity of CFR reduction directly has an
mpact on the ability of viable myocardium to
mprove its contraction upon inotropic stimulation,
s this requires increases in MBF. Viable segments
ithout contractile reserve (CR) usually have lower
FR than viable segments with CR do. The re-
ponse of viable segments to these stimuli varies
reatly from segment to segment as well as with the
ntensity and the duration of stimulation. Many
iable segments in HM exhibit a biphasic response
hen challenged by increasing levels of inotropic
timulation (26). At low levels of stimulation, and
rovided that sufficient CFR is present, systolic wall
hickening usually increases and starts earlier in
ystole. At higher levels, when the increase in
emand cannot be matched anymore by further
ncreases in MBF, systolic function again deterio-
ates and can even become worse than at baseline.
he observation of this biphasic pattern is impor-
rease of MBF in 2 Different Clinical Situations
After Revascularization
CCVS Angina Class NYHA Functional Class
Before After Before After
II 0 to I II I
IV I to II IV II
0 g of muscle); NYHA  New York Heart Association.
Table 2. Pathophysiology of Coronary Blood Flow
● In normal animals:
SE-MBF governs transmural contraction
SE-MBF is greater than epicardial MBF
● In animals with coronary artery obstruction there is:
Sensitive coupling between SE-MBF and contraction
A 2 to 1 relationship between reductions of SE-MBF and of
reduction TM-MBF
A 50% to 75% reduction of SE-MBF results in left ventricular
akinesis
After relief of an ischemic episode the hyperemia due to
vasodilation is maldistributed so that SE-MBF is still reduced
for a period of time
● In humans with hibernating myocardium:
SE-MBF is reduced
Coronary ﬂow reserve is reduced*
*It is also reduced in normal people, and patients, with signiﬁcant coronary
atherosclerosis.
SE-MBF  subendocardial myocardial blood ﬂow; TM-MBF  transmuralInc
gesmyocardial blood ﬂow.
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539ant to rule out other causes of regional dysfunction
uch as the presence of a subendocardial scar or
emodeled myocardium, both of these conditions
eing characterized by a sustained CR at both low
nd high levels of inotropic stimulation. About 20%
o 25% of viable segments do not improve function-
lly during inotropic stimulation. These segments
sually have mild reduction of resting MBF, avidly
ake up glucose under fasting conditions, and have
n almost completely exhausted MBF reserve. A low
BF reserve prevents the segments from increasing
heir oxygen consumption upon inotropic stimulation
nd hence from increasing their contractile functions.
part from the exhaustion of MBF reserve, other
actors, such as the presence and severity of cardiom-
ocytic alterations or down-regulation of beta-
drenoreceptors, may also contribute to the lack of CR
n apparently viable segments.
tructural Alterations in LVD
esides the changes in resting MBF and CFR,
everal structural alterations affect cardiomyocytes
nd extra cellular matrices in patients with chronic
M (22,27). These structural changes are mostly
ncountered in the areas of dysfunction, but can
lso be seen in remote normally contractile regions.
ost of the available information on these struc-
ural changes has been gathered from studies in
hich human myocardial biopsy specimens were
arvested at the time of coronary bypass surgery and
lso from experimental studies of HM.
icrocirculation. Histological analysis of human
ysfunctional myocardium demonstrated that the
icrovasculature was better preserved in segments
hat improved in function after revascularization
han in those that remained dysfunctional. This is
articularly true for the capillaries whose density
nd cross-sectional area are usually within the
ormal range in viable segments (28). In contrast,
here is greater heterogeneity among persistently
ysfunctional segments despite revascularization,
nd approximately half of them show significant
apillary rarefaction.
yocytes. The primary alteration is the depletion of
ontractile elements in the cardiomyocytes. In some
ells, this is limited to the vicinity of the nucleus;
hereas in others it is very extended, leaving only
ew or no sarcomeres at the cell periphery. The
pace previously occupied by the myofilaments is
sually filled with glycogen. The mitochondria are
ncreased in number and display alterations in size
nd shape. Nuclei are usually tortuous and show oniformly dispersed heterochromatin. Sarcoplasmic
eticulum is virtually absent, as are T tubules. At the
olecular level, the expression of myosin, actin,
itin, and alpha-actinin is usually reduced. Cy-
oskeletal proteins such as desmin, tubulin, and
inculin are disorganized. The expression of con-
exin 43, a major gap junction protein, and that of
uclear A-type lamins are also reduced.
xtracellular matrix. The extracellular matrix shows
ncreased amounts of type I collagen, type III
ollagen, and fibronectin in chronic LVD. Within
he widened interstitium, an increased number of
imentin-positive cells (endothelial cells and fibro-
lasts) and macrophages can usually be seen.
The severity of the structural changes that affect
chronically dysfunctional myocardium are likely to
mpact on its ability to respond to an inotropic
timulus and on the speed at which it may or may
ot recover after revascularization. Segments with
ess fibrosis or with less severe cardiomyocytic
lterations are more likely to improve in function
ollowing the administration of dobutamine or after
evascularization. Current data suggests a spectrum
f myocardial dysfunction may exist in patients with
oronary artery disease.
athophysiological Targets for the Imager
ased on the understanding of the pathophysiology
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540an be clinically imaged. The following section
escribes each of the imaging techniques that can
e used to image the key pathophysiologic sub-
trates of: 1) fibrosis and/or cellular viability; 2)
ow-metabolism; 3) microcirculation; and 4) CR.
ssessment of Fibrosis and/or Cellular Viability
he most important determinant of the return of
esting contraction following revascularization is the
everity of the underlying tissue fibrosis, and whether
t is interstitial or infarct-related. Imaging methods
uch as delayed enhancement–CMR, thallium
nd metabolic imaging using PET, echocardiogra-
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chocardiography. SPATIAL EXTENT OF LV SCAR-
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541egree of LV remodeling is usually caused by a large
umber of scarred segments. A 2-dimensional echo-
ardiography underestimates LV volumes, but LV
pacification improves the reliability of these measure-
ents. A 3-dimensional echocardiography permits
ore accurate volume measurements without needing
o make geometric assumptions, which is desirable if
he LV has been involved in multiple previous myo-
ardial infarctions (29).
The involvement of4 ventricular wall segments
y scarring (i.e., thinned segments) also identifies
he LV that is unlikely to show global functional
ecovery after revascularization. Extensive infarc-
ion also reduces LV compliance, producing a
estrictive filling pattern. A short mitral E-wave
eceleration time is associated with a small number
f viable segments or a large number of scar
egments, and deceleration time is directly related
o the degree of LVEF change after revasculariza-
ion, with 5% improvement being unusual with a
eceleration time of 180 ms (30). Segments with
ignificant transmural extent of infarction become
etracted and fibrotic as the infarct heals. A LV
nd-diastolic wall thickness of 0.5 to 0.6 cm is
ssociated with akinesis or even dyskinesia, and
hese segments usually demonstrate no CR in
esponse to dobutamine (30,31). A thinned seg-
ent is very unlikely to recover (5% probability to
ecover); thinning to 0.5 to 0.6 cm has a sensi-
ivity of 94% for infarction but its specificity is
uch lower. A segment of 0.5 to 0.6 cm may
ecover (specificity 48%) and is more likely to do so
f it augments in response to dobutamine; the
ombination of wall thickness with augmentation at
obutamine stress gives a sensitivity of 88% and
pecificity of 77% for prediction of functional re-
overy (30,31). Dobutamine stress and single-
hoton emission computed tomography (SPECT)
rovide similar degrees of additional information to
all thickness (31).
RANSMURAL EXTENT OF SCARRING. Increasing
ransmural extent of scarring is inversely related to
he likelihood of functional recovery after revascu-
arization and correlates with the degree of reduc-
ion of radial function. Wall motion scoring is too
nsensitive to distinguish minor gradations of func-
ion. The thickness of a subendocardial scar may be
dentified using myocardial contrast echocardiogra-
hy; the relative thickness of a scar and perfused
yocardium corresponds with transmural extent of
carring by magnetic resonance imaging. New
chocardiographic indices of LV deformation are
ensitive to the reductions in function caused by pontransmural scarring. Tissue velocity-based longi-
udinal strain and strain rate are reduced with suben-
ocardial scarring, although the relationship is non-
inear because of the importance of the
ubendocardium to longitudinal function. Studies
sing speckle-based (2-dimensional) strain (32)
ave shown radial or circumferential strain to be
mpaired in proportion to the transmural extent of
carring.
IRECT EVIDENCE OF VIABILITY FROM RESTING
MAGES. Myocardial deformation is impaired in
roportion to the extent of myocardial fibrosis, so
he magnitude of strain is an index of the amount of
hronically dysfunctional tissue. Unfortunately, this
ssociation is not sufficiently robust to be used in
ecision making, probably because the parameters
re load-dependent. Although tissue velocity is less
seful than strain for the assessment of regional
hanges because it is less site-specific and influ-
nced by tethering of adjacent segments, its high
emporal resolution (especially using pulsed-wave
oppler) may allow the measurement of pre-
jection velocity, which may be a load-independent
arker. Preserved pre-ejection velocity has been
eported to be a reasonable resting marker of
iability and is a predictor of the likelihood of
unctional recovery and favorable outcome (33).
agnetic resonance imaging. LATE GADOLINIUM
NHANCEMENT. Gadolinium chelates are extracel-
ular/interstitial contrast agents that enhance T1
elaxation in regions of infarction as a consequence
f the increased volume of distribution of the
helates within a collagenous scar and their delayed
ashout due to reduced capillary density (34). The
nd result is that regions of myocardial infarction
MI) appear bright on inversion recovery images
cquired 10 to 20 min after gadolinium administra-
ion. The spatial extent of late gadolinium enhance-
ent (LGE) closely mirrors the distribution of
yocyte necrosis early after MI and that of collag-
nous scarring seen at 8 weeks (35). Furthermore,
tudies have shown that in regions of the heart
ubjected to reversible injury, the retention of con-
rast does not occur (36). Regions of a chronically
ysfunctional myocardium often consist of an ad-
ixture of reversibly injured and irreversibly injured
infarcted) myocardium (37). The power of LGE
esides in its ability to distinguish these 2 states
ithin the same segment of myocardium (Fig. 3).
The ability of LGE to identify and characterize
yocardial scarring has been directly compared
ith both SPECT and PET. In a study of 91
atients with suspected or known coronary artery
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542isease, SPECT failed to correctly identify nearly
alf of the subendocardial infarcts that were
dentified by LGE (38). Another study (39)
ompared LGE to PET in 31 patients with
schemic heart failure. Infarct mass correlated
ell between the 2 modalities (r  0.81, p 
.0001), but LGE more frequently identified
ubendocardial scarring than PET did, again
eflecting its superior spatial resolution. In fact,
hen the transmural extent of scarring is 37%,
ET defines the segment as viable due to the
resence of sufficient signal from remaining via-
le mid-wall and subepicardium (40). When a
car is 37% transmural, PET defines the seg-
ent as nonviable.
The utility of LGE for identifying the likelihood
f functional recovery after revascularization was
emonstrated in a study of 50 patients imaged
efore and after revascularization (41). Eighty per-
ent of patients had some region of LGE with a
ean signal intensity that was 530% of that seen in
ormal segments. Functional recovery inversely cor-
elated with the transmural extent of scarring. In
egments with no LGE, 78% demonstrated recov-
ry of function. Only 1 of 58 segments with 75%
ransmural extent, however, showed any improve-
ent following revascularization, thus demonstrat-
Figure 3. Contrast-Enhanced Images Obtained by MRI in Chroni
Late gadolinium-enhanced images are shown in a short-axis view (u
Hyperenhancement is present (arrows) in various coronary-perfusio
circumﬂex artery, and the right coronary artery—with a range of tra
(41). LVD  left ventricular dysfunction; MRI  magnetic resonanceng the powerful negative predictive value of this anding. Several subsequent studies (42,43) have
urther supported the LGE imaging approach for
redicting functional recovery.
The standard CMR pulse sequence used for
GE imaging is an inversion recovery gradient
cho technique (44) that has been carefully vali-
ated in a canine model. This pulse sequence
equires selection of an inversion time that opti-
ally nulls normal myocardium. A recently de-
eloped phase-sensitive inversion recovery tech-
ique (45) is less sensitive to the choice of an
ncorrect inversion time and may therefore be
ore efficient. Additional novel approaches in-
lude a subtractive inversion recovery technique
sing both a long and short inversion time (46)
hat improves infarct-blood pool contrast by 247
136% compared with magnitude inversion
ecovery while maintaining signal difference-to-
oise ratio for an infarct myocardium. However,
ubtraction techniques are prone to misregistra-
ion. Another approach to improve the differen-
iation of the blood pool and infarcted subendo-
ardium is a multicontrast method using a
ombination of T1- and T2-weighted imaging
47). For patients who cannot hold their breath,
single-shot subsecond technique (48) was re-
ently validated with slightly lower sensitivity and
verall accuracy but still quite useful in the
D
r panels) and a long-axis view (lower panels) in 3 patients.
rritories—the left anterior descending coronary artery, the left
ural involvement. Reprinted, with permission, from Kim et al.
ging.c LV
ppe
n te
nsmcutely ill patient nonetheless.
ER
r
w
a
a
t
r
s
l
w
t
i
m
r
i
e
F
c
a
v
(
v
a
R
w
r
a
m
c
p
t
i
2
s
(
d
p
b
u
k
t
t
t
s
t
o
u
b
n
l
s
i
b
fl
d
r
s
b
o
p
o
a
v
a
r
r
m
a
(
a
s
t
(
o
e
c
W
r
c
v
r
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 , N O . 4 , 2 0 0 8
J U L Y 2 0 0 8 : 5 3 6 – 5 5
Rahimtoola et al.
Chronic Ischemic LVD
543ND-DIASTOLIC WALL THICKNESS AND RESIDUAL
IM OF VIABILITY. Studies with both echocardiog-
aphy and cine CMR have established end-diastolic
all thickness as an important parameter in the
ssessment of myocardial viability, although its
ccuracy, using fluorodeoxyglucose (FDG) PET as
he reference standard, is less than that of CR in
esponse to dobutamine (49). In 1 study (50),
egments that failed to improve following revascu-
arization had a significantly lower end-diastolic
all thickness (6 mm vs. 9.8 mm, p  0.001) than
hose that showed functional improvement. More
mportant than end-diastolic wall thickness alone
ay be the residual thickness of the unenhanced
im of viable myocardium beyond the area of LGE
n the subendocardium. One study (40) compared
nd-diastolic wall thickness and viable rim with
DG PET in a group of 22 patients with ischemic
ardiomyopathy. Receiver-operator characteristic
nalysis demonstrated greater area under the curve for
iable rim compared with end-diastolic wall thickness
0.95 vs. 0.86, respectively). Optimal cutoff values for
iability were 5.4 mm for end-diastolic wall thickness
nd 3.0 mm for the viable rim.
ADIONUCLIDE IMAGING: SPECT. Tracers used
ith SPECT or PET to image MBF are commonly
eferred to as “perfusion tracers,” because their uptake
nd retention mechanisms require viable myocellular
embranes. Thus, uptake and visualization of myo-
ardial regions with perfusion tracers require the
resence of working, viable myocytes. This informa-
ion is the converse of direct and indirect fibrosis
maging by echocardiography and CMR. Thallium-
01 redistribution, which reflects myocardial potas-
ium space with SPECT, and rest sestamibi imaging
with or without nitrates), which reflects mitochon-
rial membrane integrity are the 2 most common
erfusion tracers used to image cellular viability.
The evaluation of myocardial ischemia and via-
ility by thallium scintigraphy has occupied a rather
nique place in the management of patients with
nown or suspected coronary artery disease since
he late 1970s (51,52). Like potassium, thallium is
ransported across the sarcolemma membrane via
he sodium-potassium adenosine triphosphatase
ystem. The initial extraction and distribution of
hallium in the myocardium is primarily a function
f blood flow (either during stress or at rest) and is
naffected by hypoxia, chronic hypoperfusion (hi-
ernation), or post-ischemic dysfunction (stun-
ing), unless myocardial infarction is present. The
ater distribution of thallium (3 to 4 h or 24 h after
tress or rest injection), termed redistribution phase,s flow-independent and is a function of regional
lood volume and myocardial potassium space re-
ecting cellular viability (52,53). Thus, thallium
efects on early rest images that “fill-in” on delayed,
edistribution phase (termed reversible defect) repre-
ents a scintigraphic pattern of HM. In contrast,
ecause thallium is not actively taken up in regions
f scarred myocardium, defects on rest images that
ersist on redistribution images (termed irreversible
r fixed defect) represent scarred myocardium.
There are a number of thallium protocols that
re used clinically for the detection of myocardial
iability. Among the range of choices, 2 protocols
re optimized for viability detection: 1) rest-
edistribution and 2) stress-4 h-redistribution-
einjection imaging (Fig. 4). The former assesses
yocardial viability alone (54,55), and the latter
ssesses myocardial ischemia and viability
56,57). A pooled analysis of rest-redistribution
nd stress-redistribution-reinjection thallium
tudies (58,59) reported a relatively high sensi-
ivity (80% to 90% range) and modest specificity
54% to 80% range) for the prediction of recovery
f regional function after revascularization. How-
ver, these conclusions must be viewed in the
ontext of the limitations of pooled data analysis.
hen taking into consideration regions with
eversible defects (ischemia) and success of revas-
ularization (reexamining regional perfusion or
essel patency after revascularization), stress-
edistribution-reinjection thallium imaging yields
Figure 4. Thallium-201 Imaging for Myocardial Viability
Short-axis 201thallium tomograms during stress (top row), redistribu
and reinjection (bottom row) imaging in a patient with coronary ar
are extensive 201thallium abnormalities in the anterior and septal re
that persist on redistribution images but improve markedly on reintion (middle row),
tery disease. There
gions during stress
jection images.Reprinted, with permission, from Dilsizian et al. (56).
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544xcellent positive and negative predictive accu-
acy (both in the 80% to 90% range) for recovery
f function after revascularization (56,57).
In the case of technetium-99m–based perfusion
racers, both sestamibi and tetrofosmin are li-
ophilic cationic complexes that are retained within
he mitochondria due to a large negative transmem-
rane potential. Because accumulation and reten-
ion of sestamibi and tetrofosmin are related to
nergy-dependent processes that maintain mito-
hondrial membrane polarization, they may also
erve as markers of cellular viability. The adminis-
ration of nitrates to improve resting MBF prior to
njection of sestamibi or tetrofosmin appears to
mprove slightly the ability of these tracers to detect
ellular viability (60).
With regard to prediction of improvement in LV
unction after revascularization, both thallium and
echnetium-99m– based techniques have been
hown to be reasonably accurate. Reported sensitiv-
ties (58,59,61) for recovery of ventricular function
re in the 75% to 85% range, with positive- and
egative-predictive values of about 70% and 90%,
espectively. With additional enhancements to im-
ging protocols, such as nitrate-enhanced rest per-
usion imaging and gated SPECT for assessment of
unction, the accuracy of these techniques is even
igher (60,62).
ssessment of Flow-Metabolism Relationship
iable myocardial segments display a variety of
erfusion patterns.
adionuclide imaging: PET. Decreased regional
yocardial tracer uptake at rest could reflect
ither lack of cell membrane integrity in an area
f scarred myocardium or reduced MBF second-
ry to HM (dysfunctional but viable). Therefore,
n patients with chronic ischemic LV dysfunc-
ion, myocardial perfusion tracers alone may not
eliably differentiate hibernating from scarred
yocardium. In that setting, flow-independent
robes that assess intact cellular metabolic processes
ay be used as an adjunct to resting myocardial
lood flow.
8F-2-FLUORO-2-DEOXYGLUCOSE. Despite the ex-
ellent flow kinetics and biological properties of
hallium, attenuation of photons is a potential
imitation for thallium in patients with large body
abitus. Positron emission tomography systems
ave generally better sensitivity and spatial resolu-
ion than SPECT systems and provide more accu-
ate attenuation correction. Thus, metabolic imag- mng with FDG PET may provide incremental
nformation to thallium regarding myocardial via-
ility, especially in patients with severely impaired
VD (63). High-energy phosphates, such as aden-
sine triphosphate (ATP), are generated in the
yocardium by oxidative phosphorylation and gly-
olysis. In the normal myocardium, use of free fatty
cids is the preferred metabolic pathway for ATP
roduction. In the setting of myocardial isch-
mia, where local oxygen supply is reduced, the
yocardium shifts ATP production from fatty
cid metabolism (which occurs in the mitochon-
ria and is oxygen-dependent) to glucose use
which occurs in the cytoplasm and is oxygen-
ndependent).
The principle of using a metabolic tracer for
ssessing myocardial viability is based on the con-
ept that viable tissue is metabolically active, and
carred tissue is metabolically inactive. The glucose
nalogue FDG may be preserved or increased in
ypoperfused but viable myocardium, termed
etabolism-perfusion mismatch (Fig. 5) (64). Con-
ersely, FDG uptake will be decreased or absent in
ypoperfused and scarred myocardium, termed me-
abolism/perfusion match. The metabolism-perfusion
ismatch pattern represents a scintigraphic marker
f HM. The PET imaging in dysfunctional myo-
ardium had positive and negative predictive values
f 85% and 92%, respectively, for recovery of
unction after revascularization (65–71). A subse-
uent European multicenter trial (72) in 178 pa-
ients confirmed the high sensitivity of PET mis-
atch pattern for predicting functional recovery
fter revascularization.
The prognostic significance of perfusion-
etabolism mismatch pattern has been demon-
trated in several nonrandomized, retrospective
tudies with PET. Patients with perfusion-
etabolism mismatch pattern (HM) who were
reated with revascularization had lower ischemic
vents and deaths when compared with those
reated medically (7,73,74). Moreover, the extent of
he PET mismatch pattern correlated with im-
rovement in LV function, clinical course, and
agnitude of heart failure symptoms after revascu-
arization (75). Patients with matched defects (con-
ordant reduction in regional perfusion and metab-
lism), indicating a scarred myocardium, displayed
o such difference in outcomes or clinical benefit
rom revascularization (7).
The principal limitation for the widespread ap-
lication of PET imaging for the assessment of
yocardial metabolism is its availability. Currently
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545n the U.S., there are approximately 1,600 PET
ameras versus 12,000 SPECT cameras. Thus,
ET is not readily available for most practicing
ardiologists. Because SPECT cameras are more
revalent than PET cameras in the community and
ardiology offices, investigators have recently fo-
used their attention on developing gamma-
mitting metabolic radiotracers, such as beta-
ethyl-p-[123I]-iodophenyl-pentadecanoic acid
BMIPP), to make the assessment of myocardial
etabolism readily available to patients presenting
ith symptoms of heart failure or LVD (76).
ETA-METHYL-P-[123I]-IODOPHENYL-PENTA-
ECANOIC ACID. BMIPP is a fatty acid analogue
hat provides insight into myocardial metabolism
sing SPECT cameras. In a recent study, delayed
ecovery of myocardial metabolism after ischemic
njury, termed ischemic memory, was shown with
MIPP (75). Fatty acid metabolism remained sup-
ressed for a prolonged time (up to 30 h following
n ischemic episode) even after perfusion had re-
urned to normal (76,77).
Uptake of BMIPP from the plasma into myocardial
ells occurs via CD36 transporter protein present on
he sarcolemma membrane. Retention of BMIPP in
he myocardium most likely reflects activation of fatty
cids by coenzyme A, and indirectly, of cellular ATP
roduction resulting from fatty acid metabolism.
hus, in the setting of myocardial ischemia, reduction
n ATP production secondary to diminished fatty acid
etabolism is mirrored by decreased myocardial
MIPP uptake. Although BMIPP is approved for
linical use in Japan, it has not yet received approval by
he Food and Drug Administration in the U.S. In the
linical setting, the finding of persistent and prolonged
isturbances in BMIPP uptake, long after resolution
f ischemic symptoms, may provide a scintigraphic
mprint as to the underlying cause of chronic LVD.
ssessment of Microcirculation
ontrast echocardiography. The coronary microcir-
ulation is preserved in myocardium with chronic
schemic LVD. The microbubbles in echocardio-
raphic contrast agents are intravascular tracers and
he intensity of their reflected signal can be used to
emonstrate the presence and relative size of the
icrocirculation, and their rate of accumulation
elated to coronary flow. Myocardial contrast en-
ancement of dysfunctional segments at rest is
herefore a potential marker for viable myocardium.
he value of contrast echocardiography for this has
een reported in over 10 studies, with sensitivities danging from 62% to 92%, and specificity from 67%
o 87%. Nonetheless, this technique remains tech-
ically challenging and may be difficult to use in all
yocardial segments due to issues of shadowing
nd attenuation.
ssessment of CR
esting scar imaging and perfusion imaging does
ot permit distinction between viable and remod-
led myocardium. Assessment of MBF or CR is
herefore mandatory combined with perfusion,
etabolic, or scar imaging.
obutamine stress echocardiography. Viable myo-
ardium has been shown to augment function in
esponse to inotropes (e.g., dobutamine, amrinone),
oronary vasodilators (e.g., dipyridamole), arterial
asodilators (e.g., levosimendan), and low level of
xercise. However, the most widely used stressor to
ugment function is low-dose dobutamine echocar-
iography (LDDE), with an average sensitivity of
5% to 80% and a specificity of 80% to 85% for the
rediction of functional recovery both early after
nfarction as well as in the setting of chronic LVD.
ugmentation of function in response to low-dose
obutamine is a more reliable predictor of recovery
han improvement at peak dose (e.g., 40 g/kg/
in). Nonetheless, the peak-dose response is im-
ortant, because the most reliable predictor of
unctional recovery is the biphasic response (i.e.,
ugmentation at low dose with deterioration at peak
Figure 5. PET Imaging and Perfusion-Metabolism Mismatch in H
Positron emission tomography (PET) scan showing perfusion (top) t
tom) mismatch in hibernating heart as an example of preserved ca
reserve. Rubidium-82 PETs in short-axis view (top row) show marke
sion defects in the apical, inferior, inferolateral, and septal regions o
rest, which extends from distal to basal slices. [18F] 2-deoxy-2-ﬂuoro
acquired under glucose-loaded condition (lower row) show perfusi
match pattern (the scintigraphic hallmark of hibernation) in all abn
myocardial regions at rest, with the exception of the anteroseptal r
strates matched perfusion-metabolism pattern (compatible with sca
Reprinted, with permission, from Taegtmeyer and Dilsizian (64).ibernation
o metabolism (bot-
rdiometabolic
dly decreased perfu-
f the left ventricle at
glucose images
on-metabolism mis-
ormally perfused
egion, which demon-
rred myocardium).ose) indicating that the tissue is not only viable but
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546Figure 6. Resting and Dobutamine Stress Echo for Myocardial Thinning, CR, and Myocardial Ischemia
Integration of resting data and new technologies predicts functional recovery in a patient with severe dysfunction (LVEF 25%). The resting
study (A) shows no areas of thinning (1-cm markers in all walls) despite severe LV dysfunction and borderline restrictive ﬁlling (DT: 150 ms, E/A
2). Dobutamine stress shows basal inferior ischemia and mid inferior biphasic response in B. Peak-dose (40 g/kg/min) dobutamine response
showed hypokinetic septal and lateral walls had deteriorated at peak dose, which is consistent with extensive ischemia (C). CR  contractile
reserve; DT  deceleration time; E/A  early-to-late diastolic ﬁlling ratio; HR  heart rate; other abbreviations as in Figure 2.
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547lso supplied by a stenosed infarct-related artery
Figs. 6A to 6C). The extent of viability is an
mportant determinant of the likelihood of recovery
f overall LV function (e.g., characterized by a
VEF improvement of 5%). The presence of 4
egments with a biphasic response has a specificity
nd sensitivity of 80% to 90% for prediction of
lobal functional recovery. Patients demonstrating a
ignificant LVEF improvement with LDDE are
lso likely to show global functional recovery and
everse remodeling (78).
Echocardiography is an ideal initial screening test
n these patients, because of its wide availability,
ow cost, and similar levels of accuracy to other
ore expensive modalities (59). As with any non-
nvasive test, there may be false-negative and false-
ositive responses with LDDE. The reliability of
DDE is influenced by a number of other factors
part from the extent of viable tissue, and false-
egative responses may be due to reduced substrate
upply (compromised if the tissue is ischemic), loss
f the myocardial contractile apparatus, and exces-
ive fibrosis (which may splint the segment and
Viable
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Revascularization Medical
Figure 7. Prognostic Implications of Myocardial Viability
Testing
The data are derived from meta-analysis of 3,088 patients with
coronary artery disease and left ventricular dysfunction who
underwent viability testing. Death rates for patients with and
without myocardial viability treated by revascularization or med-
ical therapy are shown. In patients with viable myocardium,
there is 79.6% reduction in mortality among those who were
treated with revascularization (p  0.0001). In contrast, among
patients without evidence of viable myocardium, there was no
signiﬁcant difference in mortality with revascularization versus
medical therapy. Adapted, with permission, from Allman
et al. (7).revent it from shortening). If flow is severelyompromised, the tissue may become ischemic
efore exhibiting an augmentation response. For
his reason, LDDE should be performed with
ultiple low doses (e.g., 5 and 10 g/kg/min—
ome investigators have used a very low dose of 2.5
g/kg/min and doses higher than 10 g/kg/min),
ontinually assessing the response, as augmentation
ay be very transient and ischemia is increasingly
ikely as the heart rate increases. The chronotropic
esponse to dobutamine usually starts at doses 10
g/kg/min, although the widespread use of long-
cting beta blockers for heart failure has moved the
ow-dose threshold toward 20 g/kg/min. Another
ause of false-negative responses is damage to the
ontractile apparatus within viable myocytes, which
s caused by recurrent episodes of ischemia and
tunning. Failure to respond to dobutamine may
ot indicate lack of viability, which may still be
dentified using PET; in these situations, prolonged
ollow-up may be needed to demonstrate functional
ecovery after revascularization. Nontransmural
carring influences the likelihood of recovery of
esting function and may cause false-positive re-
ponses. Subendocardial scarring is a major contrib-
tor to resting dysfunction, so segments with non-
ransmural scarring may respond to dobutamine
ecause of augmentation of the subepicardium but
ot recover resting function after revascularization.
here are risks in the performance of peak-dose
obutamine stress in individuals with severe LVD.
he underlying reserve of the LV may be limited
nd hypotension, heart failure, and serious arrhyth-
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Figure 8. Myocardial Viability, LV Function, and Reduction in
Mortality After Revascularization
The relationship of reductions in death rate to resting left ven-
tricular ejection fraction in patients who had revascularization. In
patients with nonviable myocardium, there is no reduction of
death with revascularization. In patients with viable myocar-
dium, the lower the ejection fraction, the greater the reduction
of deaths after revascularization. Reprinted, with permission,
from Allman et al. (7). Abbreviations as in Figure 2.
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548ias may ensue if severe ischemia develops. These
ests should be performed by experienced personnel;
he test may need to be stopped at the development
f ischemia, and nitrates and oxygen may need to be
dministered. Nonetheless, there is no good evi-
ence to indicate that there is a substantial increase
f risk of dobutamine stress in the situation com-
ared with the usual risk of a significant adverse
vent in 3 out of 1,000 studies.
A problem relates to the challenges of interpreting
DDE. As with all stress echocardiographic tech-
iques, wall motion scoring is limited by subjectivity
nd technical challenges. The measurement of myo-
ardial deformation may prove to be a more reliable
eans of quantitation of this response. Strain rate at
DDE correlates with the presence of myocardial
iability evidenced by FDG imaging, with an optimal
ut-point for this purpose being a strain-rate incre-
utamine Echo 41 st./1421 pts
 PET 20 st./598 pts
TI-201 40 st./1119 pts
MRI 13 st./420 pts
9m 25 st./721 pts
10 20 30 40 50 60 70 80 90 100
Specificity (%)
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Diagnostic Accuracy of Various Techniques for Functional Recove
n of sensitivities and speciﬁcities (A) and predictive values (B) with 9
n of sensitivities and speciﬁcities (C) and predictive values (D) of the
ry of global left ventricular function. Reprinted, with permission, from
value; PPV  positive predictive value; pts  number of patients; st
thallium 201; other abbreviations as in Figures 2, 3, and 5.ent of 0.23/s (79). A strain-rate increment of
0.25/s also predicts functional recovery after revas-
ularization (sensitivity 80%, specificity 75%) (80).
agnetic resonance imaging. The demonstration of
R is an established predictor of myocardial viabil-
ty (59). As with echocardiography, CMR assess-
ent of CR is performed using the infusion of low
oses of dobutamine (5 to 10 g/kg/min). One
tudy (49) compared low-dose dobutamine CMR
o FDG PET in 35 patients with chronic MI and
egmental LVD. Using both end-diastolic wall
hickness and improvement in systolic thickening as
arkers of viability, CMR had a sensitivity, speci-
city, and diagnostic accuracy of 88%, 87%, and
2%, respectively. Using improvement in LV func-
ion post-revascularization as the reference standard
n the same patient group (50), dobutamine CMR
ad a sensitivity and specificity of 89% and 92%.
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549The utility of incorporating myocardial tagging
or the assessment of intramyocardial functional
eserve has also been demonstrated. In acute MI,
he quantitative response to dobutamine is predic-
ive of functional recovery, although the response in
he subendocardium is quite complex (81). Studies
n chronic ischemic heart disease before and after
ultivessel revascularization using tagged dobut-
mine CMR demonstrate that one-half of dysfunc-
ional segments recover resting function, and, of the
emainder, one-half demonstrate rest dysfunction
ut CR (82). One-half of these latter segments in
urn recover rest function when examined 3 years
fter revascularization (82).
Some controversy exists as to which test performs
est for predicting functional recovery among CMR-
ased techniques. Late gadolinium enhancement
learly identifies scarring, but the relationship between
carring and functional recovery in infarcts with 1% to
5% transmural infarction is complex. The perfor-
ance of dobutamine CMR has been compared with
GE in this scenario (83). Although no difference was
een in the identification of viability in segments
ithout LGE or those with scarring 75%, dobut-
mine CMR was superior in predicting recovery in
ones in which LGE demonstrated between 1% and
5% transmural scarring (84). However, the perfor-
ance of LGE varied greatly depending on the cutoff
alues used to define viability (84). Complementary
se of dobutamine CMR and LGE may prove to
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Figure 10. Diagnostic Accuracy of MRI for Post-
Revascularization Improvement in Regional Function
Sensitivity, speciﬁcity, positive predictive value (PPV) and nega-
tive predictive value (NPV) of data from various techniques with
cardiac magnetic resonance (CMR). Figure developed from data
of Schinkel et al. (86), with permission. ce-CMR  contrast-en-
hanced cardiac magnetic resonance; EDWT  end-diastolic wall
thickness; other abbreviation as in Figure 3.e the optimal strategy for predicting post-evascularization functional recovery, as shown in a
tudy (85) of 15 patients studied before and 20 weeks
fter coronary artery bypass surgery. In segments with
% to 50% infarct transmurality, as shown by LGE,
obutamine response was predictive of functional
ecovery, whereas the predictive value of LGE alone
as intermediate. Wall thickening with dobutamine
MR before revascularization correlated with wall
hickening at rest at follow-up.
This combined approach to defining viability
y CMR may be warranted in certain clinical
cenarios. Although it may not be practical to
erform low-dose dobutamine infusion on all
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Figure 11. Comparison of Diagnostic Accuracy of Dobutamine
Echocardiography and Nuclear Imaging
Sensitivity and speciﬁcity (A) and positive (PPV) and negative (NPV)
dictive value for predicting improvement in left ventricular function
obtained by a direct comparison of dobutamine echocardiography
nuclear imaging (Nucl) of 325 patients in 11 studies. In each study,
same patients underwent both tests at the same medical center. Fi(B) pre-
(DE) and
the
guredeveloped from data of Bax et al. (58), with permission.
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550atients evaluated for viability, those patients
ith multiple segments having 1% to 50% trans-
urality may benefit from this decision. In pa-
ients with no late enhancement or 50% late
nhancement, there is little to gain by adding
obutamine, and LGE remains the preferred
echnique because of its ease of use.
rognostic Implications of
yocardial Viability Testing
eyond the assessment of mere presence or ab-
ence of myocardial viability and predictive values
f the various tests for recovery of regional or
lobal LV function, it is perhaps equally impor-
ant (if not more important) to demonstrate a
urvival advantage offered by revascularization for
atients with ischemic LVD with viable myocar-
ium. In a pooled analysis consisting of 3,088
atients in 24 studies, long-term survival after
evascularization or medical therapy was deter-
ined independent of the type of viability test-
ng, which included SPECT radionuclide imag-
ng, PET, or dobutamine echocardiography (7).
n patients exhibiting predominantly viable myo-
ardium, follow-up on medical therapy was asso-
iated with very high risk, a 16% annual mortal-
ty. On the other hand, in similar patients,
evascularization was associated with an 80%
eduction in annual mortality (16% vs. 3.2%, p 
.0001), compared with medical therapy (Fig. 7).
mportantly, patients with the most severe LVD
erived the greatest benefit from revasculariza-
ion (Table 1). With worsening LVEF, the sur-
ival benefit associated with revascularization of
atients with viable myocardium increased pro-
ortionately (Fig. 8) (7).
ntegrated Imaging in Clinical Practice
one of the currently available imaging tools can
ddress all the different aspects of the complex
athophysiology of myocardial viability and hiber-
ation. Accordingly, they should often be used in
ombination to achieve the highest possible level of
iagnostic accuracy. The clinician and noninvasive
mager should note the following in the evaluation
f reversible ischemic dysfunction:
The sensitivity, specificity, positive predictive,
and negative predictive values of the various testsRest-Redistribution
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Figure 12. Comparison of Diagnostic Accuracy of Nuclear and Magnetic
Resonance Imaging for Functional Recovery After Revascularization
Relationships between recovery of function after revascularization with
contrast-enhanced cardiac magnetic resonance, and 2 thallium protocols
optimized for viability detection: 1) rest-redistribution and 2) stress-redistri-
bution-reinjection imaging are shown. Irrespective of the imaging modality
applied, the data suggest that recovery of function after revascularization is
a continuum and is coupled to the ratio of viable to scarred myocardium
within dysfunctional myocardial segments. The extent of infarct size on CMR
or percentage of thallium defect on SPECT correlated with decreasing likeli-
hood of functional recovery after revascularization. Reprinted, with permis-for recovery of regional LV function and for
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551recovery of global LV function (Figs. 9A to 9D,
Fig. 10) (86).
These studies included various methodologies,
patient populations, and end points and thus
should be interpreted with appropriate caution.
Data obtained by direct comparison of dobut-
amine echocardiography and nuclear studies in
the same patients in the same centers are shown
in Figures 11A and 11B (58).
Single-photon emission computed tomography
imaging with thallium-201 or technetium-99m
perfusion tracers is more sensitive for detecting
viable myocardium than dobutamine echocardi-
ography. Low-dose dobutamine echocardiogra-
phy is more specific for predicting recovery of
function after revascularization. Thus, markers of
CR predict functional recovery with greater speci-
ficity than do markers of preserved cell membrane
function (87). The recommended SPECT imaging
is stress-redistribution-reinjection. It provides
information about viability and ischemia. For
those who cannot undergo stress imaging, rest-
redistribution can be used.
The retrospective nature of all available studies
represents a weakness in the collective evi-
dence base. These are the only data that are
available and one should exercise some care in
their application to patient management.
LV Dy
LDDE 
CM
No Reva
LV Wal
In Area o
HE 
Match
Revascularization
HE ≤50% or
Mismatch
Revascularization
Viable Not viable
Wall Thickness ≤5-6 mm
(Probability of improvement of LV function <5%)
†
†Evaluate remote areas for CAD, ischemia if appropriate
*All patients need intensive medical therapy by standard
Algorithm 1.
CAD  coronary artery disease; CMR  cardiac magnetic resonance
 low-dose dobutamine echocardiography; LV  left ventricular; P
ization by PCI/CABG if technically feasible; SPECT  single-photon emisHowever, it should be recognized that pro-
spective, properly designed and executed stud-
ies will likely not be available for a consider-
able period. Moreover, the Schinkel et al.
review (86), from which Figures 9A to 9D and
Figure 10 are shown, was comprehensive and
included all available studies with adequate
data and follow-up. This allows for a reason-
able, and probably a very good, plan of deci-
sion making for patient management at the
present time.
There is no perfect test (95% to 100% sensitive
and specific), and therefore, there may be a need
for combination of tests.
The judgment to use test(s) at any 1 medical
center depends on the availability of the test(s)
and the skill and experience in performing the
test(s) and interpreting the results.
Mild-to-moderate improvement/severe defect
on reinjection, 50% of thallium uptake on
SPECT imaging, and 50% LGE on CMR
indicate a small probability of LV function
improvement after revascularization (Fig. 12)
(88).
The patients should first have an echocardiogram/
Doppler (or another test) to diagnose LVD.
A suggested format for diagnosis of viable myo-
cardium and need for myocardial revasculariza-
nction
 SPECT
 PET
larization
Echo
CMR if echo not satisfactory
ickness
sfunction*
% or
 Defect
Revascularization
Revascularization
HE ≤50% or
Mismatch
Not viable Viable
Wall Thickness >5-6 mm
(Probability of improvement of LV function ≥50%)
current era
HO  echocardiogram/Doppler; HE  hyperenhancement; LDDE
positron emission tomography; Revasc  myocardial revascular-sfu
and
R or
scu
l Th
f Dy
>50
ed
s of 
; EC
ET sion computed tomography; Viable  hibernating myocardium.
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552tion if coronary arteries are suitable is shown in
Algorithm 1. The format of the proposed studies
is the one which uses tests that are available at
larger medical centers and there is good volume
of data documenting the value of the tests.
LV Dy
LDDE a
No Revas
LV Wall
In Area of 
Revascularization
Wall Thickness ≤5-6 mm
(Probability of improvement of LV function <5%)
Viable Not viable
*All patients need intensive medical therapy by standards o
Algorithm 2.
Abbreviations as in Algorithm 1.
Table 3. Patients With Global LVD and Multivessel Disease
Criteria indicating LV function with low probability of
improvement with revascularization
● Major criteria:
LVWT 5 to 6 mm
No response to LDDE
SPECT negative for viability
CMR: LGE 50%
PET: negative for HM
● Minor criteria:
LVEF 0.20
LV volumes: 1 or more of the following:
By angiography: LVEDVI 200 ml/m2 and/or LVESVI 120
ml/m2
By echocardiography: LVEDVI 170 ml/m2 and/or LVESVI
90 ml/m2
Echocardiographic dimension: LVEDDI 5.5 cm2/m2
Criteria indicating LV function not likely to improve with
revascularization:
● 4 major
● 3 major plus 1 minor
● 2 major plus 2 minor
CMR  cardiovascular magnetic resonance; EDV/EDVI  end-diastolic vol-
ume/index; EF ejection fraction; ESV/ESVI end-systolic volume/index; HM
 hibernating myocardium; LDDE  low-dose dobutamine echocardiogra-
phy; LGE  late gadolinium enhancement; LV  left ventricle; LVD  left
ventricular dysfunction; PET  positron emission tomography; SPECT 9single-photon emission computed tomography; WT  wall thickness. A simplified format that proposes studies that
are most widely available to most practicing
clinical cardiologists is shown in Algorithm 2.
 Criteria suggesting LV function is not likely to
improve with revascularization are listed in Table 3.
linical Decision Making
here are several steps in the management of these
atients:
 There is a need for almost immediate diagnosis
of LVD in the clinical syndromes described
earlier in this report. Usually, this is best done by
echocardiography/Doppler studies.
 Appropriate test(s) for viability ( ischemia)
should be performed very early in the manage-
ment of these patients. Test(s) for viability and
coronary arteriography are essential prior to a
consideration for revascularization.
 The entire clinical picture, including results and
proper interpretation of the results of diagnostic
tests, should be incorporated into clinical deci-
sion making.
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